Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Lotze

Showing results (1-10 of 255) with videos related to

Pageof 26
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|August 7, 2003
The critical need for cancer biometrics: quantitative, reproducible measures of cancer to define response to therapyMichael T Lotze
Journal of Innate Immunity|November 17, 2011
Pancreatic cancer is not nobleMichael T Lotze
JAMA Oncology|July 17, 2015
Parkinson Disease and Malignant Disease: Minding Cancer's Own BusinessMary Ganguli, Michael T Lotze
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2012
The power of negative thinking: which cells limit tumor immunity?Siuwah Tang, Michael T Lotze
Annals of Surgical Oncology|March 5, 2021
ASO Author Reflection: Viruses, the Lung, and Thoracic Neoplasms: Breaking BadMichael T Lotze, Rajeev Dhupar
Nature Immunology|August 23, 2012
Tumor immunity times out: TIM-3 and HMGB1Daolin Tang, Michael T Lotze
Journal for Immunotherapy of Cancer|June 19, 2025
Reciprocal immune-epithelial interaction during breast cancer inductionNeil Carleton, Michael T Lotze
Current Opinion in Investigational Drugs (London, England : 2000)|June 21, 2006
Cancer genomics: the unknown unknownsMichael T Lotze, Yan Yu
Journal of Translational Medicine|November 1, 2007
A life in passing: Jonathan GrayMichael T Lotze, Jonathan Gray
Nature Reviews. Immunology|August 3, 2004
Inflammation and necrosis promote tumour growthJukka Vakkila, Michael T Lotze
Pageof 26

Showing results (1-10 of 255) with videos related to

Sort By:
Pageof 26
Current Opinion in Investigational Drugs (London, England : 2000)|August 7, 2003
The critical need for cancer biometrics: quantitative, reproducible measures of cancer to define response to therapyMichael T Lotze
Journal of Innate Immunity|November 17, 2011
Pancreatic cancer is not nobleMichael T Lotze
JAMA Oncology|July 17, 2015
Parkinson Disease and Malignant Disease: Minding Cancer's Own BusinessMary Ganguli, Michael T Lotze
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2012
The power of negative thinking: which cells limit tumor immunity?Siuwah Tang, Michael T Lotze
Annals of Surgical Oncology|March 5, 2021
ASO Author Reflection: Viruses, the Lung, and Thoracic Neoplasms: Breaking BadMichael T Lotze, Rajeev Dhupar
Nature Immunology|August 23, 2012
Tumor immunity times out: TIM-3 and HMGB1Daolin Tang, Michael T Lotze
Journal for Immunotherapy of Cancer|June 19, 2025
Reciprocal immune-epithelial interaction during breast cancer inductionNeil Carleton, Michael T Lotze
Current Opinion in Investigational Drugs (London, England : 2000)|June 21, 2006
Cancer genomics: the unknown unknownsMichael T Lotze, Yan Yu
Journal of Translational Medicine|November 1, 2007
A life in passing: Jonathan GrayMichael T Lotze, Jonathan Gray
Nature Reviews. Immunology|August 3, 2004
Inflammation and necrosis promote tumour growthJukka Vakkila, Michael T Lotze
Pageof 26